
Among our ten most-read stories this week: NICE has announced that more patients are eligible for a £75,000-a-vial SMA drug, …

In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …

Potentially unsafe coronavirus treatments are in the headlines this week, as President Donald Trump reportedly wants to approve Phoenix Biotechnology’s …

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …

The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it is the first …

The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, …

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning …

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …

Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …